420 with CNW — Cannabis Brand Strength Could Be More Pivotal Than Sales

In only a few short years, the cannabis industry has proven to be one of the fastest-growing and most profitable sectors in the country. Over two decades after California legalized medical cannabis, the marijuana industry has grown to a behemoth sector worth billions of dollars.

The industry has sold billions’ worth of cannabis products, filled state coffers with billions of dollars in taxes and created hundreds of thousands of new employment opportunities.

This landscape of constant growth and runaway profits attracted entrepreneurs from all over the country who were itching to gain a portion of the extremely lucrative cannabis market for themselves. However, this quickly resulted in an oversaturation of supply as more sellers jumped into the mix, crowding the market. It can be quite difficult to stand out in such an oversaturated market, especially if your business is located in a region such as Michigan, which has no statewide cap on the number of marijuana business licenses.

Data suggests that businesses that focus on brand health rather than sales have a better chance of long-term success. While some cannabis markets believe that branding still doesn’t matter in the cannabis sector, others are pouring all of their energies into creating brand awareness for their products.

In recent years, cannabis markets have taken to advertisements (as much as their home states allow), sponsor events, and even enlist celebrity brand managers to increase awareness of their products.

Others have adopted fun and quirky product designs to stand out on the shelves, targeted specific consumer segments as part of their branding, launched loyalty programs to encourage repeat customers, and created in-store campaigns to pull in new consumers or budtenders.

But even though these marketing initiatives can be costly, cannabis marketers rarely have a means of determining just how effective their marketing initiatives are. If a marketer uses several initiatives to drive sales and repeat sales, they may not know which of their marketing initiatives was responsible for boosting sales.

In such cases, tracking brand health can be a great way to determine how marketing initiatives are resonating with customers. It allows marketers to gauge how well their marketing initiatives are working both in terms of product sales and customer engagement.

Tracking brand health also helps markets to gauge customer consideration, awareness, purchase, and loyalty to each brand and gives marketers a reasonable metric on how they rank with other brands in the industry.

Furthermore, it provides clear marketing performance indicators and makes it possible for marketers to track the effectiveness of their tactics over the long term. These metrics are also helpful to firms like Advanced Container Technologies Inc. (OTC: ACTX) which are ancillary to the cannabis space.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Senators in Nebraska Debate Refiled Marijuana Legalization Measures

Senators in Nebraska recently held a meeting to discuss a newly filed legislation that would legalize medical cannabis in the state. The lawmakers spent the hearing listening to testimonies from experts and advocates on the therapeutic benefits of the cannabis plant.

The members of the Judiciary Committee discussed a medical cannabis bill that was filed by Senator Anna Wishart nearly a month ago, before meeting later in the day to discuss separate measures that would legalize recreational cannabis in the state. Wishart has been at the forefront of cannabis reform in Nebraska for several years now, pursuing this reform through both activist-led ballot campaigns and legislative avenues.

Her medical cannabis bill would allow patients suffering from certain medical conditions to use cannabis for medical purposes with a doctor’s recommendation. Wishart has stated that her measure is one of the most conservative medical marijuana bills in the country and that it would allow patients in Nebraska to access the medical care they deserve. She noted that growing evidence had proven marijuana’s ability to alleviate conditions such as seizures and chronic pain. Furthermore, she added that medical cannabis would help address the need for opioid use as it has proven to be an effective pain killer, without the side effects typically associated with opioid use.

Her bill would have created a medical cannabis system that allowed patients to buy and possess up to two and a half ounces of cannabis if they were suffering from any of the stipulated eligible conditions. The qualifying medical conditions include chronic pain, HIV/AIDS, epilepsy and cancer. The legislation would also ban smoking cannabis and home growing for patients with qualifying conditions.

At the recent medical cannabis hearing, Wishart stated that her goal was to prevent families that needed medical cannabis treatments from leaving Nebraska to go to other states with medical cannabis markets. She noted that her bill had already been amended to address concerns that had been raised during the last session, such as eliminating provisions that allowed vaping or smoking cannabis.

Wishart added that she was willing to make the legislation even narrower as long as it remained centered on patients who needed medical cannabis.

However, state Attorney General Mike Hilgers opposed the legislation and testified that launching a medical cannabis market would be in direct conflict with the federal prohibition of cannabis. The legislation also received opposition from a Nebraska State Patrol representative who said passing the medical cannabis bill would encourage the growth of an illicit market and increase rates of impaired driving in the state.

If the measures gain eventual approval, companies that wish to participate in the industry could find themselves needing funding from the likes of REZYFi Inc. or other entities that have created a niche around meeting the financing needs of marijuana companies in the absence of access to mainstream banks.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi Inc. are available in the company’s newsroom at https://cnw.fm/REZY

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Bipartisan Senators Reintroduce Revised Bill on Cannabis Research for Veterans

Last week, a group of senators re-introduced a measure to promote studies on the use of marijuana by veterans. It is expected that an identical bill will be introduced in the House in the near-term.

A congressional source has revealed that the measure’s introduction in the House maximizes the likelihood of its passage through both chambers.

The bipartisan measure in question, the VA Medicinal Cannabis Research Act, directs that the U.S. Veterans Affairs’ department look into the medical potential of cannabis for military veterans, in particular those who suffer from chronic pain and post-traumatic stress disorder. The measure was sponsored by chair Jon Tester of the Senate Veterans’ Affairs Committee and Senator Dan Sullivan. This resolution was carried in previous sessions by Representative Lou Correa.

Sullivan added that they had an obligation to better understand and explore new remedies for mental health conditions that were both effective and safe, and could offer veterans some hope.

Despite protests from VA officials, an earlier version of this resolution was advanced by a House committee. Other versions moved through committee in 2018 and 2020. However, none of these was enacted into law.

The older versions directed that clinical trials evaluating the therapeutic potential of marijuana in the treatment of chronic pain and PTSD be carried out. This is slightly different from the most recent version, which was revised to also include a requirement for a retroactive observation study on the experiences of veterans who have used cannabis for such treatment previously, outside of the clinical trail context.

Other amendments to the bill’s new version include the removal of language that directed studies to use no less than seven marijuana varieties. This comes after an alliance of veterans’ service organizations penned a letter to congressional leaders last year requesting that they approve a cannabis and veterans research legislation before the end of the session. This action was unsuccessful.

As more states revise their drug laws, a larger market will potentially open not just for “plant-touching” companies but also ancillary companies that focus on addressing the needs of the cannabis companies, such as Advanced Container Technologies Inc. (OTC: ACTX).

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — California Releases Grants Worth $15M to Cannabis Social Equity Initiatives

On Feb. 10, 2023, the state of California announced that it had given out grants totaling $15 million to fund regional initiatives to advance fairness in the cannabis business. The Office of the Governor of Economic and Business Development (G0-Biz) gave the money to 16 counties and cities throughout the state through the Marijuana Equity Grants Program for Local Jurisdictions. The applications began toward the end of 2022.

This is in line with California’s plans to finance future and ongoing fairness initiatives for individuals who are disproportionately affected by the war on drugs with money from the marijuana tax.

The lowest grant recipient will be San Diego, which is expected to receive $350,000, while Oakland (the highest awardee) gets $1,996,487. A total of $35 million was made available for localities throughout the state in an earlier round of grants under the program, for which GO-Biz began accepting applications in 2021. The funding cap for this year and next year is $15 million.

Last year, the department reported that it had given 78 grants to groups across the state to help the social and economic advancement of areas that have been disproportionately affected by the fight against drugs. In the meantime, the state’s Department of Marijuana Control declared that the state intends to award universities that undertake studies into marijuana policy and science grants worth $20 million through cannabis taxes. These grants will cover projects such as preserving the genetic makeup of “legacy” isolates and deterring monopolies in the legal cannabis industry.

California is taking additional steps to broaden the market for cannabis outside of its borders. Regulatory authorities recently asked the attorney general of the state for an official opinion regarding whether permitting marijuana commerce across state lines would put California at “considerable risk” of federal regulatory action.

Last year, the governor signed legislation granting him the authority to enter into agreements with other jurisdictions to freely trade marijuana goods. The call for advice by DCC is an important first step that might ultimately result in the legislation being put into effect. In addition, Newsom would want to see marijuana decriminalized on a federal level, so that the cannabis producers in his state will be able to “lawfully supply the entire nation.”

Furthermore, a state senator has reintroduced a proposal to decriminalize the possession of some psychedelic substances after his previous attempt was unsuccessful in the waning moments of last year’s session.

As the cannabis industry grows even more, the need for funding from other sources such as REZYFi Inc. will grow given that the chance of a banking bill being passed by Congress is looking to be dimmer now that the GOP is in control of the House.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi Inc. are available in the company’s newsroom at https://cnw.fm/REZY

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – AmeriCann Inc. (ACAN) Releases Financial Results Showing Four Consecutive Quarters of Positive Net Income

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, is reporting on its quarter ending December 2022; the report included both financial and operational highlights and noted that the company has seen four straight quarters of positive net income. Other financial highlights include the following: the company is seeing accelerating revenue, net income and adjusted operating EBITDA, which is driven by the performance of ACAN’s Massachusetts Cannabis Center (“MCC”); revenue for the quarter totaled $734,764, which was a 13% increase compared to the quarter ended December 2021; Adjusted EBITDA for the quarter increased by 49.5%, reaching $111,794; and annual gross margins were 98.1%. Much of the company’s financial success stems from products produced and manufactured at Building 1, its initial building at its development in Freetown, Massachusetts. The company receives base rent and a revenue participation fee of 15% of all gross monthly sales of cannabis, cannabis-infused products and non-cannabis products produced at the center. “AmeriCann’s focus on financial performance has produced excellent results, with four consecutive quarters of positive net income,” said AmeriCann CEO Tim Keogh in the press release. “We look forward to building upon these results for the future by expanding operations at our Massachusetts Cannabis Center to produce even greater cash flow.”

To view the full press release, visit https://cnw.fm/madhI

About AmeriCann Inc.

AmeriCann is a cannabis company that develops cultivation, processing and product manufacturing facilities. AmeriCann uses greenhouse technology, which is superior to the current industry standard of growing cannabis in warehouse facilities under artificial lights. According to industry experts, by capturing natural sunlight, greenhouses use 25% fewer lights, and utility bills are reduced by as much as 75% compared to typical warehouse cultivation facilities. As such, AmeriCann’s Cannopy System enables cannabis to be produced with a greatly reduced carbon footprint, making the final product less expensive. Additionally, greenhouse construction costs are nearly half of warehouse construction costs. AmeriCann is also designing GMP-certified cannabis extraction and product manufacturing infrastructure. The company has secured provisional licenses to produce cannabis-infused products, including beverages, edibles, topicals and concentrates. AmeriCann plans to operate a marijuana product manufacturing business at the Massachusetts Cannabis Center. For more information about the company, please visit www.Americann.co.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – ECGI Holdings Inc. (ECGI) Announces Planned Acquisition Representing ‘Plug-and-Play’ Access to Dynamic Market

ECGI Holdings (OTC: ECGI), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, today announced its entry into a definitive agreement to acquire East West Pharma Group Inc. (“EWPG”), a Wyoming corporation with specialized equipment and experienced personnel, including leaders in the cannabinoid extraction and product manufacturing space. As previously announced, the acquisition represents a shift in the company’s strategy by becoming part of the $2.7 billion cannabis manufacturing, extract and concentrates marketplace. “Now that the agreement is in place, we are excited to hit the ground running,” said ECGI CEO Danny Wong. “This acquisition represents plug-and-play access to one of the most dynamic cannabis product markets on the planet. We now have the relationships, equipment and team to compete for significant market share.”

To view the full press release, visit https://cnw.fm/fJffn

About ECGI Holdings Inc.

ECGI Holdings, which plans to operate as Elite Cannabis Group, is reorganizing as an acquisition-oriented corporation with California-based targets including undercapitalized and distressed licensed cannabis assets, properties zoned for cannabis cultivation and processing, and cannabis companies operating in market sectors with nationwide expansion possibilities. For additional information, please contact the company at info@ecgiholdings.com.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Canada Yet to Make Progress on Cannabis Consumption Lounges

Cannabis consumption lodges have been controversial since the first consumption lounge was launched in Los Angeles in 2019. Consumption lounges have made little headway in the years since, and they are still a rarity across most of America.

The situation is the same up north in Canada, where the country has had legal recreational cannabis for five years now but still hasn’t made any effort to craft a legal framework for permanent consumption lounges. The most regulatory authorities have done is issue temporary outdoor consumption licenses for events such as music festivals, but there has been little action, if any, to address the lack of public consumption lounges.

Like most American states with legal cannabis markets, Canada has outlawed the public consumption of cannabis and only allows users to consume cannabis in private residences. But, while the United States has taken some steps to build up the consumption lounge segment, with the lounges becoming increasingly common in Nevada and California, and New York opening its first cannabis consumption lounge late last year, Canadian authorities have made few moves toward growing the sector.

Postdoctoral fellow at the University of Guelph’s School of Hospitality and Food & Tourism Management Susan Dupej argues that marijuana consumption in Canada is still a grey area. Dupej, a student of marijuana tourism in Canada, states that the few entrepreneurs that have opened consumption lounges have been able to use their smarts to maneuver around Canada’s regulations to avoid running afoul of the law.

She explained that the scarcity of legal consumption lounges in Canada has been a missed opportunity that could have significantly increased the country’s cannabis tourism potential. Given that public consumption of cannabis is outlawed, tourists who would like to dabble in Canada’s adult-use cannabis market have nowhere to consume cannabis once they purchase it. Dupej stressed that Canada has to quickly figure out consumption lounge regulations and put them in place.

The federal government may have been in charge of legalizing recreational marijuana, but the country’s municipal and provincial governments in charge of regulating public smoking and vaping have been slow to take action. As it stands, none of the trio of the largest recreational cannabis markets in Canada have a single approved permanent consumption lounge. This means that these regions are missing out on profits from cannabis tourists who would have come over to Canada for its adult-use market.

It doesn’t seem that regulators will take any action on cannabis lounges soon; an Ontario attorney general spokesman revealed in a recent interview that the province did not expect any changes to the country’s cannabis framework.

For enterprises that are pursuing the development of FDA-approved cannabis therapeutics, such as India Globalization Capital Inc. (NYSE American: IGC), no such concerns about where the products will be used exists because approved medicines can be used anywhere.

NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — California Could Make Interstate Cannabis Commerce a Reality Sooner

Is the Golden State indeed facilitating cannabis cross-state trading? California marijuana regulators have had extensive discussions with the state’s attorney general. Top state officials from the Cannabis Control Department (DCC) laid out the lawsuit over how California might avoid federal restrictions if state authorities decide to approve marijuana exports throughout state boundaries in an eight-page memo to the state AG’s office on Jan. 27, 2023.

Executives in the cannabis sector and legal professionals expressed their opinions about the memo, labeling it a significant development that, if realized, would require more time.

Matthew Lee, DCC chief lawyer, and Nicole Elliott, DCC executive director, have requested that attorney general Rob Bonta express an opinion on whether exporting cannabis to other states would pose a significant legal risk to California, given the state’s law on controlled substances. They pointed out that Congress is prohibited from limiting how states manage their imports and exports by the constitution.

The move follows the September signing of Proposed Bill 1326 by California Governor Gavin Newsom, which might establish interstate trade agreements if the following factors were satisfied:

Nationwide legalization, which won’t happen anytime soon.
A law is passed prohibiting the government from allocating funds to stop cannabis shipment between states.
The United States Justice Department issues a statement or memo approving interstate marijuana trade.
The completion of an examination of the applicable legislation, which includes federal court rulings and executive regulations, incuding the attorney general providing a reasoned report stating that state laws enforcing clinical or adult-usage commercial cannabis activity would not pose a major legal hazard to California under the federal CSA law.

Several states have made efforts to allow interstate commerce, including Oregon, New Jersey and Washington, DC. The specifics of how interstate commerce may operate are not known, despite the fact that California’s move represents a significant stride toward permitting cannabis businesses to sell cannabis outside of the state.

Outdoor-grown marijuana has long been a staple of the Emerald Triangle area of California, and a number of those cultivators have gone legitimate to participate in the legal sector. To help reduce excessive production, those marijuana growers want to see the whole nation opened up to legal trading.

Additionally, they want to create an appellations system that would enable California marijuana to be handled and promoted similarly to the celebrated Champagne of France.

At the moment, since marijuana air travel is subject to federal regulation, California would have to find a neighboring state to be a willing trading partner. Additionally, even if the state succeeds in gaining a partner, it must accept all of the conditions outlined in SB 1326. The new law mandates, among other things, that the partnering state adhere to all of the same testing, packaging, and labeling requirements as California’s marijuana market.

Should interstate commerce commence, there is likely to be a flurry of activity among companies sending inquiries to companies such as REZYFi Inc. which specialize in providing alternative funding to marijuana entities in need of a cash injection to boost operations and take advantage of market opportunities.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi, Inc. are available in the company’s newsroom at https://cnw.fm/REZY

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Releases Financial Report, Corporate Update for Q3

India Globalization Capital (NYSE American: IGC) (dba IGC Inc.) is reporting on its financial and corporate performance for the third fiscal quarter 2023. Highlights of the report include a focus on the company’s phase 2 clinical trial on IGC-AD1 for agitation in dementia from Alzheimer’s disease. The company reports that the number of sites participating in the trial has reached four: three sites in the United States and one site in Canada. In addition, based on patient enrollment and interest in the study, the company plans to more than double the number of trial sites, from the planned 4 or 5 sites to between 10 and 12 sites. According to the report, the trial will include 146 participants, with one-half receiving a placebo and the other one-half receiving IGC-AD1. Over a six-week period, the trial will study the efficacy of IGC-AD1 in treating agitation in dementia from Alzheimer’s disease.

The company noted that it is hoping to offer the first natural tetrahydrocannabinol (“THC”)-based medication for treating agitation in dementia from Alzheimer’s disease. Another report highlight was net revenue for the company, which totaled $332,000, an increase of 133% compared to $142,000 in the three months ended Dec. 31, 2021. In addition, net revenue totaled $745,000 for the nine months ended Dec. 31, 2022, a 172% increase when compared to $275,000 for the nine months ended Dec. 31, 2021. “We are delighted with the progress made during this quarter, highlighted by the commencement of the phase 2 clinical trial for our drug candidate IGC-AD1 for the safety and efficacy of the drug on agitation in dementia due to Alzheimer’s disease,” said India Globalization Capital CEO Ram Mukunda in the press release. “This represents a milestone in our progress towards gaining FDA approval for IGC-AD1, which we believe has the potential to revolutionize the treatment of Alzheimer’s disease as the first and only low-dose, natural, THC-based candidate currently undergoing FDA trials. Moreover, our sales of natural products, which include gummies and pain relief creams, are seeing increased traction in the market. We’re encouraged by our third-quarter results and look forward to driving continued expansion through the balance of fiscal 2023.”

To view the full press release, visit https://cnw.fm/kxRE6

About India Globalization Capital Inc.

India Globalization Capital IGC develops advanced cannabinoid-based formulations for treating diseases and conditions including, but not limited to, Alzheimer’s disease, period cramps (“dysmenorrhea”), premenstrual syndrome (“PMS”) and chronic pain. The Company has two investigational drug assets targeting Alzheimer’s disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer’s cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer’s disease such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol (“THC”) based formulation that is currently in a 146-person Phase 2B safety and efficacy clinical trial for agitation in dementia due to Alzheimer’s (clinicaltrials.gov, NCT05543681). The Company also markets two wellness brands, Holief™ and Sunday Seltzer™. Holief™ targets women experiencing premenstrual syndrome and menstrual cramps, and Sunday Seltzer™ is a lifestyle, hemp-infused energy beverage brand. The Company is headquartered in Maryland, USA, and has historically operated an infrastructure segment based in India. For more information, visit the company’s website at www.IGCInc.us.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

REZYFi, Inc. Leveraging Everchanging Cannabis Landscape to Tap into Possible Legislation-Driven Growth for California Cannabis Industry

REZYFi is a real estate-oriented mortgage company that primarily targets licensed and permitted cannabis companies and owners of real estate who lease to cannabis companies
The company is keen on capitalizing on possible opportunities brought by new and pending cannabis legislation
Recently, the California Department of Cannabis Control sought the legal opinion of the state Attorney General’s office on whether or not interstate cannabis commerce will be viable, given the signing of a state bill to allow the transportation and distribution of cannabis products to other states
Should the letter yield a positive opinion, legal interstate cannabis commerce could be a game-changer for the California cannabis industry

As states, which have been largely responsible for every advance in legal cannabis, of course, backed by the tolerance of the US Department of Justice, continue to evermore inch the industry forward, companies in the space are keenly watching. One of these is REZYFi, a real estate-oriented mortgage company that primarily targets licensed and permitted cannabis companies and owners of real estate who lease to cannabis companies.

The bills, which expand the opportunities and market for REZYFi and other players in the space, have been introduced and/or signed into state law in a number of states, including California. In September 2022, Governor Gavin Newsom signed several bills to expand the legal cannabis market and remedy the harmful effects of bygone cannabis prohibition. Among these bills was Senate Bill 1326, which set the stage for licensed California marijuana companies to transport or distribute cannabis or cannabis products outside the state (https://cnw.fm/owUuS).

Specifically, it “would authorize the Governor to enter into an agreement with another state or states authorizing medicinal or adult-use commercial cannabis activity, or both, between foreign licensees, who are licensed under the laws of other state or states, and entities operating with a [California] state license…” (https://cnw.fm/P8zxo).

However, the bill stipulated that an agreement entered by the Governor can only take effect if one of four criteria is met, one of which requires the state Attorney General to issue a written opinion that the interstate cannabis trade “will not result in significant legal risk to the State of California under the federal Controlled Substances Act.”

It is pursuant to this criterion that the California Department of Cannabis Control (“DCC), through General Counsel Matthew Lee and Director Nicole Elliott, wrote a letter in late January asking the state Attorney General’s office its opinion on the matter. On their part, Lee and Elliott argued that interstate cannabis commerce would not result in significant legal risk to California (https://cnw.fm/kg7az).

The letter has spawned a lot of excitement, with major players in the legal cannabis space calling it a significant development. Should it yield a positive opinion, legal interstate cannabis commerce is poised to be a game-changer, with some observers noting it could indeed prove profitable (https://cnw.fm/vytft). It would, for instance, allow producers in California to access markets in new states, giving the state’s cannabis industry the tools it needs to drive growth.

According to an article in Forbes (https://cnw.fm/YVyAy), which quotes the head of Alliance for Sensible Markets, Adam Smith, interstate cannabis commerce bills “are indicative of a realization among forward-looking state leaders that state-siloed markets are unsustainable. In natural producer states like California, thousands of small farms and businesses are on the verge of collapse due to a lack of access to the markets these growing regions have traditionally served. In consumer states, where cannabis is more difficult or expensive to grow at scale, thousands of existing and potential small businesses will wait years for a still-limited and overpriced supply chain. Opening these markets will give those businesses immediate access to thousands of existing, world-class suppliers at more competitive pricing.”

REZYFi is uniquely positioned to benefit from the ever-evolving legal cannabis space. The company is led by a management team that has extensive experience in the cannabis and hemp marketplaces. This, REZYFi believes, allows it to understand the changing landscape of the cannabis industry and source the best opportunities in the sector. Additionally, the team holds significant managerial expertise and experience in a diverse range of real estate and financing subsectors, which allows the company to tailor financing packages to meet the unique needs of cannabis businesses. REZYFi is licensed in 36 states with offices in West Covina, California and Miami, Florida.

For more information, visit the company’s website at www.REZYFi.com.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://cnw.fm/REZY

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.